Yuval Cohen, Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 550 shares at $1.95 ($1K) on 2015-08-24, disclosed to the SEC on 2015-08-25.
Open-market purchase of $1k CRBP by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CRBP | SELL | 2025-10-27 | $942K | — | Filing → |
| CRBP | SELL | 2025-02-18 | $125K | — | Filing → |
| CRBP | SELL | 2024-06-18 | $5.9M | — | Filing → |